Evidence-based prescribing of statins: a developing world perspective

H T Ong

doi:10.1371/journal.pmed.0030050

Evidence-based prescribing of statins: a developing world perspective

PLoS Med. 2006 Mar;3(3):e50. doi: 10.1371/journal.pmed.0030050. Epub 2006 Feb 21.

Author

H T Ong¹

Affiliation

¹ H. T. Ong Heart Clinic, Penang, Malaysia. htyl@pd.jaring.my

Abstract

Although statins reduce the incidence of cardiovascular disease, they are expensive. How should trial evidence on statins be applied to a resource-poor setting?

MeSH terms

Cardiovascular Diseases / prevention & control*
Cost-Benefit Analysis
Developing Countries*
Drug Utilization
Ethnopharmacology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
Lipids / blood
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids